GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B7178 L-748,337Summary: Competitive β3-adrenoceptor antagonist B7178 L-748,337Summary: Competitive β3-adrenoceptor antagonist
-   B6660 SDZ SER 082 fumarateSummary: 5-HT2B/2C receptor antagonist B6660 SDZ SER 082 fumarateSummary: 5-HT2B/2C receptor antagonist
-   B7177 B-HT 933 dihydrochlorideSummary: α2-adrenoceptor agonist B7177 B-HT 933 dihydrochlorideSummary: α2-adrenoceptor agonist
-   B6653 SB 216641 hydrochlorideSummary: h5-HT1B antagonist B6653 SB 216641 hydrochlorideSummary: h5-HT1B antagonist
-   B7147 JP 1302 dihydrochlorideSummary: α2C-adrenoceptor antagonist B7147 JP 1302 dihydrochlorideSummary: α2C-adrenoceptor antagonist
-   B6641 SB 224289 hydrochlorideSummary: 5-HT1B receptor antagonist B6641 SB 224289 hydrochlorideSummary: 5-HT1B receptor antagonist
-   B7141 BucindololSummary: beta adrenergic blocker B7141 BucindololSummary: beta adrenergic blocker
-   B6632 SR 57227 hydrochlorideSummary: 5-HT3 receptor agonist B6632 SR 57227 hydrochlorideSummary: 5-HT3 receptor agonist
-   B7132 ST 91Summary: α2-adrenoceptor agonist B7132 ST 91Summary: α2-adrenoceptor agonist
-   B6574 BW 723C86 hydrochlorideTarget: 5-HT2 ReceptorsSummary: 5-HT2B agonist B6574 BW 723C86 hydrochlorideTarget: 5-HT2 ReceptorsSummary: 5-HT2B agonist
